Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports
(Reuters) -Summit Therapeutics and AstraZeneca are discussing a partnership deal worth as much as $1...
3rd July, 2025
(Reuters) -Summit Therapeutics and AstraZeneca are discussing a partnership deal worth as much as $1...
3rd July, 2025

(Reuters) -French voucher and benefits company Pluxee reported an 11.1% organic rise in its third-qu...
3rd July, 2025
(Reuters) -OpenAI said on Wednesday it has not partnered with Robinhood for the stock tokens the tra...
2nd July, 2025
(Reuters) -The English Premier League and Microsoft on Tuesday announced a five-year partnership whe...
1st July, 2025
PARIS (Reuters) -French carmaker Renault said on Tuesday it will report an extraordinary loss of abo...
1st July, 2025
By David Brunnstrom and Humeyra Pamuk WASHINGTON (Reuters) -U.S. Secretary of State Marco Rubio host...
1st July, 2025
-OpenAI said it has no active plans to use Google's in-house chip to power its products, two days af...
30th June, 2025
ZURICH (Reuters) -Siemens has recruited Amazon executive Vasi Philomin to its new position of head o...
30th June, 2025

LONDON (Reuters) -A Cayman Islands' law legalising same-sex civil partnerships was upheld by a Londo...
30th June, 2025
SEOUL (Reuters) -North Korea's state media showed on Monday leader Kim Jong Un draping coffins with...
30th June, 2025

By Hadeel Al Sayegh DUBAI (Reuters) -United Arab Emirates' Tabreed and private equity firm CVC's inf...
30th June, 2025
BERLIN (Reuters) -Germany is aiming to establish a joint German-Israeli cyber research centre and de...
29th June, 2025